Ruxolitinib as an alternative to hydroxyurea in essential thrombocythemia in the setting of nonhealing ulcers. [PDF]
Ricke C, Ross F.
europepmc +1 more source
Essential Thrombocythemia, Acquired von Willebrand Disease, and Acquired Pernicious Anemia: A Case of Potential Beneficial Autoimmunity. [PDF]
Marfo E +4 more
europepmc +1 more source
Recurrent central retinal artery occlusion as the initial manifestation of essential thrombocythemia: A case report. [PDF]
Chen M, Du C, Lan H, Liu J.
europepmc +1 more source
Myelofibrotic transformation in essential thrombocythemia
Juergen Thiele, Hans Michael Kvasnicka
doaj +1 more source
Prognostic Scores and Risk Stratification of Myeloproliferative Neoplasms: 2026 Updates. [PDF]
Al-Zubaidi N +3 more
europepmc +1 more source
Monitoring of JAK2V617F allele burden in patients with essential thrombocythemia. [PDF]
Koh JS +8 more
europepmc +1 more source
Dysplastic Megakaryocytes in a Gallbladder Neck Lymph Node in a Patient With Essential Thrombocythemia: A Case Report. [PDF]
Balcı M.
europepmc +1 more source
Ruxolitinib reverses systemic vasculitis driven by JAK2 V617F-mutated essential thrombocythemia: a case report. [PDF]
Ashida Y +14 more
europepmc +1 more source
Response to therapy and prognosis according to molecular characterization in <i>CALR</i>-mutated essential thrombocythemia. [PDF]
Santaliestra M +28 more
europepmc +1 more source

